EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Phasic Arterial Mechanics and Ventriculo-Arterial Dyssynchrony in Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis of Arterial Systole, Arterial Diastole and Pharmacological Phase Restoration

Phasische arterielle Mechanik und ventrikulo-arterielle Dyssynchronie bei Herzinsuffizienz mit erhaltener Ejektionsfraktion: Systematische Übersicht und Metaanalyse zu arterieller Systole, arterieller Diastole und pharmakologischer Phasenwiederherstellung

Georgică Târtea, Cristina Văcărescu, Dragoș Cozma iD

Diagnostics · 01.11.2026 · 16 (21) · 3599

DOI: 10.3390/diagnostics16213599 ↗

Auf einen Blick

Die Übersichtsarbeit zeigte bei HFpEF im Mittel höhere Indizes arterieller Steifigkeit als bei Kontrollen. Für eine verzögerte reflektierte Welle ergab sich kein Nachweis.

Fragestellung

Sind die beiden Phasen der arteriellen Mechanik bei HFpEF messbar gestört, und können vordefinierte Wirkstoffklassen sie verbessern?

Methode

Systematische Übersicht und Metaanalyse; Suche in MEDLINE/PubMed, Scopus und Web of Science bis 10. September 2026; 236 erfüllten die Kriterien, 84 lieferten quantitative Daten.

Ergebnisse

Bei HFpEF waren C-F-PWV (+1,72 m/s; 95 %-KI +0,73 bis +2,70; k = 16), B-A-PWV (+2,24 m/s; +1,38 bis +3,10; k = 7), AIx (+4,51 %; +1,36 bis +7,65; k = 10) und CAVI (+1,00; +0,29 bis +1,71; k = 5) höher. In RCTs senkten Wirkstoffklassen den herzfrequenzkorrigierten AIx zunächst, nicht jedoch nach Einbezug von 10 weiteren Studien.

Einschränkungen

Heterogenität war insgesamt erheblich. Für fünf von sechs gepoolten Indizes umfassten die 95%-Vorhersageintervalle die Null.

Schlussfolgerung der Autor:innen

Arterielle Steifigkeitsindizes waren bei HFpEF im Mittel höher; der relevante pharmakologische Effekt betraf die Wellenreflexionsamplitude und nicht die Aortenleitungssteifigkeit. Die phasische Einordnung bleibt eine Hypothese.

Kernaussagen

  • HFpEF mit höheren Steifigkeitsindizes gegenüber Kontrollen
  • Pharmakotherapie beeinflusste vor allem die Wellenreflexionsamplitude
  • Kein Nachweis einer verzögerten reflektierten Welle

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 01.11.2026. Verfasst von Georgică Târtea und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University of Medicine and Pharmacy of Craiova, 2 Petru Rareș Street, 200349 Craiova, Romania. Die Arbeit nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Arterial stiffness is usually treated as a scalar load. We instead framed it as a timing problem, defining arterial diastole as compliant reservoir filling during left ventricular (LV) systole and arterial systole as elastic recoil during LV diastole, and we asked whether the two phases were measurably disturbed in heart failure with preserved ejection fraction (HFpEF), and whether pre-specified drug classes could restore them.

Methods

We searched MEDLINE/PubMed, Scopus, and Web of Science from inception to 10 September 2026 (3835 records). After deduplication, 2043 records were screened and 376 full texts were assessed, of which 236 met the eligibility criteria and 84 contributed quantitative data. Random-effects meta-analyses used DerSimonian–Laird estimations with Hartung–Knapp–Sidik–Jonkman confidence intervals; the risk of bias was assessed with the Newcastle–Ottawa Scale and Cochrane RoB 2.

Results

Compared with controls without heart failure, patients with HFpEF or diastolic dysfunction with preserved ejection fraction had higher carotid–femoral pulse wave velocity (mean difference +1.72 m/s, 95% CI +0.73 to +2.70; k = 16; p = 0.002), higher brachial–ankle pulse wave velocity (+2.24 m/s, +1.38 to +3.10; k = 7; p = 0.0007), a higher augmentation index (+4.51%, +1.36 to +7.65; k = 10; p = 0.010), and a higher cardio-ankle vascular index (+1.00, +0.29 to +1.71; k = 5; p = 0.017). In randomised trials, pre-specified drug classes lowered the heart-rate-corrected augmentation index relative to comparators (−2.18%, −3.51 to −0.85; k = 11; p = 0.004), although this did not persist when ten further eligible trials were added by generic inverse variance (−1.36%, −2.78 to +0.07; k = 15; p = 0.060). They did not change carotid–femoral pulse wave velocity (−0.11 m/s, −0.40 to +0.18; k = 18; p = 0.428), an estimate that became significant when trials at an overall high risk of bias were excluded (−0.21 m/s, −0.41 to −0.02; k = 13; p = 0.036). Reflected-wave transit times did not differ significantly (−5.09 ms; k = 4), and the pooled correlation between arterial stiffness and longitudinal strain was not significant (r = −0.28, −0.65 to +0.20; k = 4; p = 0.162). Heterogeneity was substantial throughout, and 95% prediction intervals included the nulls for five of the six pooled indices, with the single exception being brachial–ankle pulse wave velocity.

Conclusions

Arterial stiffness indices were on average higher in HFpEF, with substantial heterogeneity and prediction intervals that included the nulls for five of the six indices; under restrictions of clinically or haemodynamically defined HFpEF, the augmentation index differences lost significance (p = 0.071) while carotid–femoral pulse wave velocity was only marginal (p = 0.050). In randomised trials, the component that responded to current pharmacotherapy was the wave-reflection amplitude and not aortic conduit stiffness; this reduction derived entirely from hypertensive populations and did not survive the inclusion of ten additional eligible trials (−1.36%, −2.78 to +0.07; k = 15; p = 0.060). No analysis in this review demonstrated that the reflected wave was delayed. The phasic framework is therefore presented as an interpretation and hypothesis for prospective testing, and the phasic indices themselves remain critically under-reported.

Schlagwörter

Stichwörter der Autor:innen

arterial diastolearterial stiffnessarterial systoleaugmentation indexglobal longitudinal strainheart failure with preserved ejection fractionpulse wave velocityventriculo-arterial couplingwave reflection

Autor:innen und Institutionen

  • Department of Cardiology, University of Medicine and Pharmacy of Craiova, 2 Petru Rareș Street, 200349 Craiova, Romania.
  • Research Center of the Institute of Cardiovascular Diseases Timișoara, 13A Gheorghe Adam Street, 300310 Timișoara, Romania.
  • Cardiology Clinic of the Institute of Cardiovascular Diseases Timișoara, 300310 Timișoara, Romania.

ORCID-Profile: Dragoș Cozma

Zitieren

APA

Târtea, G., Văcărescu, C., & Cozma, D. (2026). Phasic Arterial Mechanics and Ventriculo-Arterial Dyssynchrony in Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis of Arterial Systole, Arterial Diastole and Pharmacological Phase Restoration. Diagnostics, 16(21), 3599. https://doi.org/10.3390/diagnostics16213599

Vancouver

Târtea G, Văcărescu C, Cozma D. Phasic Arterial Mechanics and Ventriculo-Arterial Dyssynchrony in Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis of Arterial Systole, Arterial Diastole and Pharmacological Phase Restoration. Diagnostics. 2026;16(21):3599. doi:10.3390/diagnostics16213599

BibTeX
@article{Trtea2026,
  author = {Târtea, Georgică and Văcărescu, Cristina and Cozma, Dragoș},
  title = {Phasic Arterial Mechanics and Ventriculo-Arterial Dyssynchrony in Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis of Arterial Systole, Arterial Diastole and Pharmacological Phase Restoration},
  journal = {Diagnostics},
  year = {2026},
  volume = {16},
  number = {21},
  pages = {3599},
  doi = {10.3390/diagnostics16213599}
}
Kostenlos starten →